Impact of Capsulectomy Type on Post-Explantation Systemic Symptom Improvement: Findings From the ASERF Systemic Symptoms in Women-Biospecimen Analysis Study: Part 1 Print
Caroline Glicksman, MD, MSJ, Patricia McGuire, MD, Marshall Kadin, MD, Marisa Lawrence, MD, Melinda Haws, MD, Jill Newby, PhD, Sarah Ferenz, BA, James Sung, MD, FCAP, Roger Wixtrom, PhD

Aesthetic Surgery Journal, sjab417

Background: Breast Implant Illness (BII) is a term used to describe a variety of symptoms by patients with breast implants for which there are no abnormal physical or laboratory findings to explain their symptoms. There currently exists a difference of opinion among clinicians and patients concerning the diagnosis and treatment of patients self-reporting BII.

>> View on the Aesthetic Surgery JournalĀ  Website